Latest Breaking News On - Cipla gulf fz lcc - Page 1 : comparemela.com

Cipla s Gulf arm to market, sell 4 biosimilar medicines in NZ, Australia Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand, the company said in a regulatory filing PTI | March 3, 2021 | Updated 07:47 IST Drug major Cipla on Tuesday said its Gulf subsidiary is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand. Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand, the company said in a regulatory filing.

New zealandNishant saxenaInternational business europe emergingCipla gulfInternational businessEmerging marketsSumatriptan nasal sprayCipla gulf armCipla gulf fz lccCipla alvotech partnershipCipla biosimilar medicinesCipla biosimilar medicines in australiaCipla biosimilar medicines in new zealandCeo of interபுதியது ஜீலாந்துநிஷாந்த் சகஷெண